Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001920731 | SCV002186554 | pathogenic | Fanconi anemia complementation group O | 2023-10-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr287Lysfs*15) in the RAD51C gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAD51C are known to be pathogenic (PMID: 20400964, 21990120, 24800917, 29278735). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RAD51C-related conditions. ClinVar contains an entry for this variant (Variation ID: 1411600). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003464227 | SCV004208020 | likely pathogenic | Breast-ovarian cancer, familial, susceptibility to, 3 | 2023-02-02 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003464227 | SCV004932633 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 3 | 2024-01-03 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |